By Admin at 13 Oct 2016

About 5 percent of breast cancer patients develop cancer in the other breast (contralateral breast cancer) within 10 years of their initial diagnosis. Drugs including tamoxifen and aromatase inhibitors are often prescribed to patients to reduce this risk, but researchers from the U.S. National Institutes of Health wanted to find out just how beneficial the drugs were in real-life settings.

By Admin at 26 Aug 2016

Aromatase inhibitors are often used to shrink breast tumors prior to surgery, but new research suggests it may be wise to reevaluate the tumor again just prior to surgery to monitor its changes and decide if a new course of treatment would be appropriate.

By Admin at 18 Mar 2016

According to an updated committee opinion from The American College of Obstetricians and Gynecologists (ACOG), topical estrogen appears to be safe for women with breast cancer (or breast cancer survivors).